249 related articles for article (PubMed ID: 1670057)
1. Fluconazole resistance of Candida krusei.
Manso E; Montillo M; Discepoli G; Leoni P
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
[TBL] [Abstract][Full Text] [Related]
2. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
[TBL] [Abstract][Full Text] [Related]
3. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole and Candida krusei fungemia.
Persons DA; Laughlin M; Tanner D; Perfect J; Gockerman JP; Hathorn JW
N Engl J Med; 1991 Oct; 325(18):1315. PubMed ID: 1922232
[No Abstract] [Full Text] [Related]
5. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
6. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Jandourek A; Brown P; Vazquez JA
Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
[No Abstract] [Full Text] [Related]
7. Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Solomkin JS
New Horiz; 1993 May; 1(2):202-13. PubMed ID: 7922404
[TBL] [Abstract][Full Text] [Related]
8. [Fungemia caused by Candida krusei in a female patient with AIDS].
Laguna F; Martínez-Suárez JV; Adrados M
Med Clin (Barc); 1994 Nov; 103(17):678. PubMed ID: 7808072
[No Abstract] [Full Text] [Related]
9. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
10. [Candidiasis of the liver following successful chemotherapy of acute myeloid leukemia (Fab type 6) and recovery with oral fluconazole therapy].
Keiser G; Schmid M; Ishak KG; Wirth W; Vogt M
Schweiz Med Wochenschr; 1996 Apr; 126(17):713-7. PubMed ID: 8668982
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients.
Di Mario A; Sica S; Salutari P; Ortu La Barbera E; Marra R; Leone G
Haematologica; 1997; 82(3):362-3. PubMed ID: 9234594
[TBL] [Abstract][Full Text] [Related]
13. [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].
Manabe A; Ebihara Y; Saito A; Takahashi K; Hosoya R
Rinsho Ketsueki; 1997 Aug; 38(8):669-73. PubMed ID: 9311273
[TBL] [Abstract][Full Text] [Related]
14. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Minari A; Hachem R; Raad I
Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
[TBL] [Abstract][Full Text] [Related]
15. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
[TBL] [Abstract][Full Text] [Related]
16. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
Wingard JR; Merz WG; Rinaldi MG; Johnson TR; Karp JE; Saral R
N Engl J Med; 1991 Oct; 325(18):1274-7. PubMed ID: 1669837
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Brockmeyer NH; Hantschke D; Olbricht T; Hengge UA; Goos M
Mycoses; 1991; 34 Suppl 1():83-6. PubMed ID: 1818270
[TBL] [Abstract][Full Text] [Related]
18. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological characteristics of fatal Candida krusei fungemia in immunocompromised febrile neutropenic children.
Agirbasli H; Otlu B; Bilgen H; Durmaz R; Gedikoglu G
Infection; 2008 Feb; 36(1):88-91. PubMed ID: 18084719
[No Abstract] [Full Text] [Related]
20. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Rex JH; Pappas PG; Karchmer AW; Sobel J; Edwards JE; Hadley S; Brass C; Vazquez JA; Chapman SW; Horowitz HW; Zervos M; McKinsey D; Lee J; Babinchak T; Bradsher RW; Cleary JD; Cohen DM; Danziger L; Goldman M; Goodman J; Hilton E; Hyslop NE; Kett DH; Lutz J; Rubin RH; Scheld WM; Schuster M; Simmons B; Stein DK; Washburn RG; Mautner L; Chu TC; Panzer H; Rosenstein RB; Booth J;
Clin Infect Dis; 2003 May; 36(10):1221-8. PubMed ID: 12746765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]